Persigehl, Thorsten
Lennartz, Simon
Schwartz, Lawrence H.
Article History
Received: 10 October 2019
Accepted: 16 December 2019
First Online: 3 January 2020
Ethics approval and consent to participate
: Not applicable.
: Given by all authors.
: SL received travel and research support from Philips Healthcare, outside the submitted work. SL and TP received expense allowance and travel cost compensation.by Bristol-Myers Squibb for attending an iRECIST expert meeting, outside the submitted work. LHS reports grants and consulting fees from Novartis, grants from Astellas, Eli Lilly, Merck, Pfizer, consulting fees from GSK, outside the submitted work.